Stryker (SYK) Capital Expenditures (2009 - 2026)
Stryker's (SYK) quarterly Capital Expenditures came in at $202.0 million in Q2 2026, up 10.38% year-over-year from $183.0 million in Q2 2025, and up 21.69% quarter-over-quarter from $166.0 million in Q1 2026.
Analysis
Stryker (SYK) Capital Expenditures (2009 - 2026) Analysis & Trends
Stryker (SYK) has reported Capital Expenditures for 18 consecutive years, with $202.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Capital Expenditures rose 10.38% year-over-year to $202.0 million in Q2 2026; TTM through Jun 2026 was $823.0 million, a 10.92% increase from a year earlier, with the FY2025 full-year figure at $761.0 million, up 0.79% from the prior year.
- Capital Expenditures was $202.0 million for Q2 2026 at Stryker, up from $166.0 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $268.0 million in Q4 2025 and troughed at $119.0 million in Q1 2022.
- A 5-year average of $169.3 million and a median of $159.0 million in 2023 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures surged 83.45% in 2024 and dropped 26.35% in 2025, its largest moves.
- Over 5 years, Capital Expenditures stood at $188.0 million in 2022, then dropped by 22.87% to $145.0 million in 2023, then jumped by 83.45% to $266.0 million in 2024, then rose by 0.75% to $268.0 million in 2025, then declined by 24.63% to $202.0 million in 2026.
- The last three Capital Expenditures figures came in at $202.0 million (Q2 2026), $166.0 million (Q1 2026), and $268.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 112.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 503.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 202.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 195.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 66.90 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -96.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 84.70 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 54.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 202.00 Mn |
| Mar 31, 2026 | 166.00 Mn |
| Dec 31, 2025 | 268.00 Mn |
| Sep 30, 2025 | 187.00 Mn |
| Jun 30, 2025 | 183.00 Mn |
| Mar 31, 2025 | 123.00 Mn |
| Dec 31, 2024 | 266.00 Mn |
| Sep 30, 2024 | 170.00 Mn |
| Jun 30, 2024 | 152.00 Mn |
| Mar 31, 2024 | 167.00 Mn |
| Dec 31, 2023 | 145.00 Mn |
| Sep 30, 2023 | 148.00 Mn |
| Jun 30, 2023 | 152.00 Mn |
| Mar 31, 2023 | 130.00 Mn |
| Dec 31, 2022 | 188.00 Mn |
| Sep 30, 2022 | 138.00 Mn |
| Jun 30, 2022 | 143.00 Mn |
| Mar 31, 2022 | 119.00 Mn |
| Dec 31, 2021 | 206.00 Mn |
| Sep 30, 2021 | 130.00 Mn |